drugset / Trial / NCT03620591

Lidocaine and Analgesia After Laparoscopic Cholecystectomy

NCT03620591 ↗

Completed 98 enrolled Larissa University Hospital
RandomizedParallel-groupDouble-blindSupportive care

Summary

The purpose of this study is to evaluate how effective is the intraoperative use of lidocaine to attenuate postoperative pain and opioids consumption after laparoscopic cholecystectomy

Timeline

Start
2018-07-02
Primary completion
2022-01-31
Completion
2022-01-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 2 mg/kg —

Indications

No indication recorded.